End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.4 SEK | +0.39% |
|
-0.77% | +53.89% |
12/06 | EQL Pharma Receives Approval for Listing to Nasdaq Stockholm Main Market | MT |
15/05 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.89% | 14Cr | |
-41.61% | 1.34TCr | |
-37.21% | 1TCr | |
-18.63% | 720.52Cr | |
-13.88% | 559.09Cr | |
-12.49% | 488.04Cr | |
-3.21% | 457.36Cr | |
+68.00% | 440.43Cr | |
-4.97% | 400.32Cr | |
-30.40% | 272.01Cr |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024